Abstract 1912: Study on the role of targeting ERBB and its potential resistance mechanism in biliary tract cancer
Abstract Purpose: Biliary tract cancer (BTC) is a kind of malignant digestive system tumors without a targeted drug approved in the clinic. A high proportion of gene mutations and abnormal expressions of ERBB pathway have been reported in BTC. However, there are few studies on targeting ERBB in BTC....
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 80; no. 16_Supplement; p. 1912 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
15.08.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!